Latest News about BNTX
Recent news which mentions BNTX
Got $1,000? Here's a Dirt-Cheap Big Pharma Stock to Buy
March 15, 2022
From Motley Fool
96 Biggest Movers From Yesterday
March 15, 2022
From Benzinga
Why Is Novavax (NVAX) Stock in the Spotlight Today?
March 14, 2022
From InvestorPlace
Mid-Afternoon Market Update: Dow Turns Negative; Turquoise Hill Resources Shares Spike Higher
March 14, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
March 14, 2022
From Benzinga
From Benzinga
From Motley Fool
50 Stocks Moving In Monday's Mid-Day Session
March 14, 2022
From Benzinga
Pfizer-BioNTech's COVID-19 Shot Moderately Effective Against Omicron In Kids Aged 5 to 15, CDC Study Shows
March 14, 2022
From Benzinga
Pfizer CEO says fourth COVID shot will be needed, shots for young kids could start in May
March 13, 2022
From MarketWatch
Is It Too Late to Buy BioNTech Stock?
March 12, 2022
From Motley Fool
Two years of COVID-19: How the pandemic changed the way we shop, work, invest and get medical care
March 10, 2022
From MarketWatch
From Benzinga
Why BioNTech Stock Dropped 12.4% in February
March 07, 2022
From Motley Fool
Benzinga Bulls And Bears Of The Past Week: Shopify, Palantir, Apple, Meta, Twitter, Johnson & Johnson, American Express And More
March 05, 2022
From Benzinga
From Motley Fool
From Motley Fool
Why Moderna and BioNTech Tumbled on Thursday
March 03, 2022
From Motley Fool
Johnson & Johnson's COVID-19 Vaccine Less Effective Against Hospitalization, French Study Shows
March 03, 2022
From Benzinga
From Motley Fool
Is BioNTech Stock a Buy Now?
March 02, 2022
From Motley Fool
Markets Fall As Russia-Ukraine Tensions Escalate; American Express, Boeing See Sharp Drops
March 01, 2022
From Benzinga
Pfizer/BioNTech's COVID-19 Vaccine Mere 12% Effective In Kids 5-11 Years, New York Study Shows
March 01, 2022
From Benzinga
From MarketWatch
Maravai LifeSciences Rejects Sartorius' $11B Takeover Bid: Reuters
February 28, 2022
From Benzinga
From Motley Fool
Moderna’s Covid Shot Alone Isn’t Enough to Revitalize a Sagging Stock
February 25, 2022
From InvestorPlace
Longer Waiting Period Between mRNA COVID-19 Doses May Cut Heart Inflammation Risk, CDC Suggests
February 25, 2022
From Benzinga
Got $5,000? These 2 Growth Stocks Are Down 60% From Their Highs
February 24, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.